Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA surgery"
DOI: 10.1001/jamasurg.2021.3748
Abstract: Importance Traditionally, liver transplant (LT) for alcohol-associated liver disease (ALD) requires 6 months of abstinence. Although early LT before 6 months of abstinence has been associated with decreased mortality for decompensated ALD, this practice remains… read more here.
Keywords: early standard; free survival; relapse free; liver disease ... See more keywords
High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Cancer"
DOI: 10.1002/ijc.30726
Abstract: Lung cancer is the leading cause of cancer related death, and the past years’ improved insight into underlying molecular events has significantly improved outcome for specific subsets of patients. In particular, several new therapies that… read more here.
Keywords: number; relapse free; lung cancer; cancer ... See more keywords
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease
Sign Up to like & getrecommendations! Published in 2018 at "Strahlentherapie und Onkologie"
DOI: 10.1007/s00066-018-1343-x
Abstract: PurposeTo assess the impact of postmastectomy radiotherapy (PMRT) on overall survival and relapse-free survival among breast cancer patients with T1–T2 N1 disease who received standard adjuvant systemic therapy.MethodsThis is an individual patient data pooled analysis… read more here.
Keywords: radiotherapy; free survival; relapse free; pmrt ... See more keywords
Survival outcomes for breast cancer patients who decline recommended treatment: a propensity score-matched analysis
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Surgical Oncology"
DOI: 10.1016/j.ejso.2020.11.026
Abstract: BACKGROUND For patients with breast cancer who decline recommended treatments, available data examining survival outcomes are sparse. We compared overall survival and relapse-free survival outcomes between patients with breast cancer who declined recommended primary treatments… read more here.
Keywords: treatment; breast cancer; free survival; relapse free ... See more keywords
Reply from Authors re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer is Safe and Will Remain Unchanged. Eur Urol 2017;71:130-131.
Sign Up to like & getrecommendations! Published in 2017 at "European urology"
DOI: 10.1016/j.eururo.2016.11.004
Abstract: We appreciate the opportunity to respond to the insightful comments made by Prof. Albers [1]. Indeed, we confirm relapse risk for clinical stage I testicular cancer is low after 2 yr, and acknowledge the important… read more here.
Keywords: clinical stage; surveillance; relapse; relapse free ... See more keywords
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month.
Sign Up to like & getrecommendations! Published in 2021 at "Tuberculosis"
DOI: 10.1016/j.tube.2021.102081
Abstract: We investigated the preclinical efficacy and safety/tolerability of biodegradable polymeric particles containing isoniazid (INH) and rifabutin (RFB) dry powder for inhalation (DPI) as an adjunct to oral first-line therapy. Mice and guinea pigs infected with… read more here.
Keywords: free cure; relapse free; tuberculosis; containing isoniazid ... See more keywords
Reducing the initial number of rituximab maintenance-therapy infusions for ANCA-associated vasculitides: randomized-trial post-hoc analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology"
DOI: 10.1093/rheumatology/kez621
Abstract: OBJECTIVE The randomized, controlled MAINRITSAN2 trial was designed to compare the capacity of an individually tailored therapy [randomization day 0 (D0)], with reinfusion only when CD19+ lymphocytes or ANCA had reappeared, or if the latter's… read more here.
Keywords: post hoc; rituximab; trial; relapse free ... See more keywords
Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004253
Abstract: Purpose The aim of this study was to determine if radiomic features combined with sarcopenia measurements on pretreatment 18F-FDG PET/CT can improve outcome prediction in surgically treated adenocarcinoma esophagogastric cancer patients. Patients and Methods One… read more here.
Keywords: free survival; relapse free; survival; pet ... See more keywords
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer science"
DOI: 10.1111/cas.15834
Abstract: Large-scale genomic sequencing of colorectal cancers has been reported mainly for Western populations. Differences by stage and ethnicity in the genomic landscape and their prognostic impact remain poorly understood. We investigated 534 Japanese stage III… read more here.
Keywords: free survival; relapse free; stage iii; colorectal cancer ... See more keywords
Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-064216
Abstract: Introduction Rituximab (RTX) effectively prevents relapses in patients with complicated steroid-sensitive nephrotic syndrome (SSNS). The 1-year relapse-free survival rate is approximately 30% in children after the first episode of SSNS treated with standardised corticosteroids. Whether… read more here.
Keywords: first episode; relapse free; rate; nephrotic syndrome ... See more keywords
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
Sign Up to like & getrecommendations! Published in 2020 at "ESMO Open"
DOI: 10.1136/esmoopen-2020-001040
Abstract: Background There is a need for improved selection of patients for adjuvant chemotherapy after resection of non-metastatic colorectal cancer (CRC). Regulator of chromosome condensation 2 (RCC2) is a potential prognostic biomarker. We report on the… read more here.
Keywords: chemotherapy; relapse free; rcc2 expression; adjuvant chemotherapy ... See more keywords